Research Labs

Molecular pathologist Marc Ladanyi studies the molecular pathogenesis of sarcomas, lung cancer, and mesothelioma.

Mechanisms of genetic and epigenetic cooperativity which drive myeloid transformation; Elucidating and modeling evolution from hematopoietic stem/progenitor cells to clonal hematopoiesis and then to myeloid malignancies; Identification and credentialing novel therapeutic dependencies in myeloid malignancies

Physician-scientist Megan Lim studies the molecular pathogenesis of lymphoma.

Physician-scientist Ingo Mellinghoff studies signal transduction alterations in primary brain tumors.

Computational biologist Quaid Morris uses artificial intelligence techniques and develops machine learning algorithms to study gene regulation, cancer evolution, clinical informatics, and other topics in systems biology.

Led by Dr. Irene Orlow, the Molecular Epidemiology Laboratory participates in self-initiated research & supports investigations from the Population Sciences Research and Clinical Research programs that involve handling and testing of a variety of human specimens.

Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.

Human Oncology and Pathogenesis Program Chair Charles Sawyers develops molecularly targeted cancer therapy.

Physician-scientist Bhuvanesh Singh focuses on delineating the role of ubiquitination in cancer pathogenesis.

Physician-scientist David Solit studies human oncology and pathogenesis, genomics, oncogenes and tumor suppressors, cancer therapeutics, and clinical trials.